The Enteral Syringe Market is Predict to reach USD 556.9 Million by 2031, at a CAGR of 5.1%

Enteral Syringe Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Enteral Syringe Market size is expected to reach $556.9 million by 2031, rising at a market growth of 5.1% CAGR during the forecast period.

Patients with chronic illnesses that affect their digestive or swallowing abilities may need medications that are difficult to administer orally. Enteral syringes allow for the delivery of these medications directly into the gastrointestinal tract, ensuring effective treatment. In paediatric and geriatric populations, where oral medication might be challenging or unsafe, enteral syringes provide a reliable method for administering necessary medications

The Adults segment is registering a CAGR of 4.8 % during the forecast period. Adults, particularly older adults, are more likely to suffer from chronic diseases such as cancer, diabetes, and neurological disorders. These conditions often require enteral feeding to ensure adequate nutrition when oral intake is insufficient or impossible. Chronic conditions often necessitate long-term enteral nutrition support, leading to sustained demand for enteral syringes in the adult population.

The Hospitals segment led the Global Enteral Syringe Market by End User in 2023; thereby, achieving a market value of $342 Million by 2031. Hospitals provide specialized medical care for patients with severe or complex health conditions that often require enteral feeding. Enteral syringes are essential tools for delivering nutrition and medications directly into the stomach or intestines of these patients.

The Disposable segment is growing at a CAGR of 4.8 % during the forecast period. Disposable enteral syringes are designed for single use, eliminating the risk of cross-contamination between patients. This is particularly crucial in healthcare settings where infection control is a top priority.

Full Report: https://www.kbvresearch.com/enteral-syringe-market/

The North America region dominated the Global Enteral Syringe Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $187 Million by 2031. The Europe region is anticipated to grow at a CAGR of 4.9% during (2024 - 2031). Additionally, The Asia Pacific region would witness a CAGR of 5.6% during (2024 - 2031).

List of Key Companies Profiled

• Boston Scientific Corporation
• Nestlé S.A.
• Fresenius SE & Co. KGaA
• Becton, Dickinson and Company
• Braun Melsungen AG
• Cardinal Health, Inc.
• Moog Inc.
• Cook Medical, Inc.(Cook Group)
• Thermo Fisher Scientific Inc.
• Medela AG

Enteral Syringe Market Report Segmentation

By Age Group

• Adults
• Pediatrics

By End User

• Hospitals
• Ambulatory Surgical Centers
• Homecare

By Type

• Disposable
• Reusable

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Related Reports:

North America Enteral Syringe Market Size | Forecast 2031

• August-2024
• 111 Pages

LAMEA Enteral Syringe Market Size | Analysis Report 2031

• August-2024
• 119 Pages

Europe Enteral Syringe Market Size & Trend Report | 2031

• August-2024
• 119 Pages

Asia Pacific Enteral Syringe Market Size | Forecast 2031

• August-2024
• 119 Pages